Delivery Order SPE2DB22D2007-SPE2DB25FJ3HP
Award Date 7/25/25
Potential Completion Date 7/28/25
Potential Value $22K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Xifaxan 550 mg tablets (60-count) with a ceiling value of $1,954.87. The award was issued on July 21, 2025, with an ultimate completion date of July 22, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and is to be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Xifaxan 550 mg tablets (60-count) under a firm fixed price contract with a ceiling value of $24,364.10 and an ultimate completion date of July 22, 2025. This is a non-set-aside competitive award, with performance to be executed at the vendor's Conshohocken, Pennsylvania location. The delivery order is issued as a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $7,403.14 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Xifaxan 550 mg tablets (60-count units). This competitively awarded, firm fixed-price contract is not designated as a set-aside and specifies a place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of July 22, 2025. The contract represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply framework with the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Xifaxan 550 mg with a ceiling value of $5,936.37. This competitively awarded, firm fixed-price delivery order was issued on July 25, 2025, with an ultimate completion date of July 28, 2025. The contract represents a pharmaceutical supply fulfillment supporting federal medical procurement needs, with performance occurring at the contractor's corporate office location in Conshohocken,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $10,087.24 firm fixed-price contract provides the DLA with 4,563,517,205 units of the drug Xifaxan 550 mg tablets. The contract has a completion date of February 2, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of Xifaxan 550 mg tablets. The total ceiling value of the contract is $11,682.85 and the period of performance runs through March 18, 2024. This delivery order appears to be part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, which serves as the...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $17,979.25 and a performance period through June 18, 2025. The contract is not set aside and was awarded on June 17, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
- This federal contract award, valued at $7,409.44, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Xifaxan 550 mg tablets, a medication used to treat certain gastrointestinal conditions. This is a firm fixed-price delivery order contract with an ultimate completion date of April 28, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide XIFAXAN 550 MG TABLET 60S. The contract is a firm fixed-price delivery order with a ceiling value of $18,424.99 and a completion date of May 20, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of XIFAXAN 550 mg tablets. The contract has a ceiling value of $28,160.03 and runs through January 9, 2025. It is a firm-fixed-price contract, with no set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...